Lundbeck plans re-structure to improve its ability to launch new medicines
20 June 2013 | By H. Lundbeck A/S
Lundbeck's initiative could lead to a reduction of around 50-55 positions in Europe...
List view / Grid view
News
Pfizer, GSK, and Siemens form R&D Consortium with ICES
20 June 2013 | By A*STAR Institute of Chemical and Engineering Sciences (ICES)
New programme aims to increase productivity with technology solutions for pharmaceutical and chemical sectors...
New test to help doctors determine personalized treatment path for patients with hepatitis C
20 June 2013 | By Abbott
Abbott has introduced the first FDA-approved HCV genotyping test...
FDA approves U.S. product labeling update for Sprycel®
20 June 2013 | By Bristol-Myers Squibb Company
Data added to Sprycel U.S. labeling are among the longest follow-up data of current CML treatment options...
Top-line results for SAVOR-TIMI-53 cardiovascular outcomes trial of ONGLYZA® (SAXAGLIPTIN)
19 June 2013 | By AstraZeneca
AstraZeneca and Bristol-Myers Squibb announced top-line results...
Curie-Cancer and Sanofi cooperate in research on ovarian cancer
19 June 2013 | By Sanofi
Preclinical program of translational research to identify new target proteins...
GSK receives offer for its thrombosis brands and related manufacturing site
18 June 2013 | By GlaxoSmithKline
GlaxoSmithKline has received an offer for its thrombosis brands...
Daiichi Sankyo submits a New Drug Application in Japan for the antiplatelet agent prasugrel
18 June 2013 | By Daiichi Sankyo
The application is based on the results of a phase 3 trial...
Sanofi to present new clinical data at the American Diabetes Association 73rd Scientific Sessions
18 June 2013 | By Sanofi
"an important opportunity for Sanofi to share significant data..."
AstraZeneca selects location for new global R&D centre and corporate headquarters in Cambridge, UK
18 June 2013 | By AstraZeneca
"AstraZeneca’s investment is excellent news for the UK life sciences industry..."
Johnson & Johnson announces definitive agreement to acquire Aragon Pharmaceuticals, Inc.
17 June 2013 | By Johnson & Johnson
Late-stage prostate cancer treatment strengthens oncology pipeline...
Gilead announces interim Phase 2 data for Idelalisib
17 June 2013 | By Gilead Sciences, Inc.
Gilead Sciences announced interim results from a single-arm, open-label Phase 2 study evaluating idelalisib...
New long-term data reinforce safety profile of Pradaxa® for stroke prevention in AF
17 June 2013 | By Boehringer Ingelheim
New long-term data from the RELY-ABLE® study...
Teva strengthens respiratory franchise with acquisition of MicroDose Therapeutx
17 June 2013 | By Teva Pharmaceutical Industries Ltd.
Teva has entered into a definitive agreement to acquire MicroDose Therapeutx...
Any Assay, Any Wavelength, Any Bandwidth with the new CLARIOstar® high performance microplate reader
17 June 2013 | By BMG LABTECH
Over the years, many different assays have been designed...
